PE20011003A1 - METALOPROTEASE INHIBITORS - Google Patents
METALOPROTEASE INHIBITORSInfo
- Publication number
- PE20011003A1 PE20011003A1 PE2000001097A PE0010972000A PE20011003A1 PE 20011003 A1 PE20011003 A1 PE 20011003A1 PE 2000001097 A PE2000001097 A PE 2000001097A PE 0010972000 A PE0010972000 A PE 0010972000A PE 20011003 A1 PE20011003 A1 PE 20011003A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alkenyl
- alkinyl
- sulfonylamino
- biphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A BIFENIL-4-SULFONILAMINO DE FORMULA I, R1 ES OH, NHOH; R2 ES H, OH, ALCOXI, ALQUILO, ENTRE OTROS; R3 ES H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; R4 ES (CR7R7`)k-X-(CR8R8')l-E-A; k Y l SON 0-4; R7, R7', R8, R8' SON H, ALQUILO, ENTRE OTROS; X ES O, S, SO, SO2, NR9, ENTRE OTROS; R9 Y R9' H, ALQUILO, ALQUENILO, ENTRE OTROS; E ES UN ENLACE, O, S, SO, SO2, NR10; R10 Y R10' SON H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; A ES H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; A JUNTO CON R7, R7', R8, R8', R9, R9', R10, R10' FORMAN UN HETEROCICLO; R5 ES H, ALQUILO, ALQUENILO, ALQUINILO, HETEROALQUILO, ENTRE OTROS; R6 ES ALQUILO, ALQUENILO, ENTRE OTROS; G ES S, O, NR11, R11C=CR11', ENTRE OTROS; R11 Y R11' SON H, ALQUILO, ALQUENILO, ENTRE OTROS; Z ES CICLOALQUILO, HETEROCICLOALQUILO; L-(CR12R12')aR13, ENTRE OTROS; a ES 0-4; L ES CC, HC=CH, N=N, O, S, SO2; R12 Y R12' SON H, ALQUILO, ALQUENILO, ENTRE OTROS; R13 ES H, ARILO, HETEROARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS ACIDO (2R,3S)-2-(4'-METOXI-BIFENIL-4-SULFONILAMINO-3-(4-METIL-BENCILOXI)-3-TIAZOL-2-IL-PROPIONICO, ACIDO (2R,3S)-2-(4'-METILSULFANIL-BIFENIL-4-SULFONILAMINO)-3-(4-METIL-BENCILOXI)-3-TIAZOL-2-IL-PROPIONICO, ENTRE OTROS. EL COMPUESTO I ES INHIBIDOR DE METALOPROTEASAS Y PUEDE SER UTIL PARA TRATAR ARTRITIS, CANCER, TRASTORNOS CARDIOVASCULARESREFERS TO BIPHENYL-4-SULFONYLAMINO OF FORMULA I, R1 IS OH, NHOH; R2 IS H, OH, ALCOXY, ALKYL, AMONG OTHERS; R3 IS H, ALKYL, ALKENYL, ALKINYL, AMONG OTHERS; R4 IS (CR7R7 ') k-X- (CR8R8') l-E-A; k AND l ARE 0-4; R7, R7 ', R8, R8' ARE H, ALKYL, AMONG OTHERS; X IS O, S, SO, SO2, NR9, AMONG OTHERS; R9 AND R9 'H, ALKYL, ALKENYL, AMONG OTHERS; E IS A LINK, O, S, SO, SO2, NR10; R10 AND R10 'ARE H, ALKYL, ALKENYL, ALKINYL, AMONG OTHERS; A IS H, ALKYL, ALKENYL, ALKINYL, AMONG OTHERS; TOGETHER WITH R7, R7 ', R8, R8', R9, R9 ', R10, R10' FORM A HETEROCYCLE; R5 IS H, ALKYL, ALKENYL, ALKINYL, HETEROALKYL, AMONG OTHERS; R6 IS RENT, ALKENYL, AMONG OTHERS; G IS S, O, NR11, R11C = CR11 ', AMONG OTHERS; R11 AND R11 'ARE H, ALKYL, ALKENYL, AMONG OTHERS; Z IS CYCLOALKYL, HETEROCYCLOALKYL; L- (CR12R12 ') aR13, AMONG OTHERS; a ES 0-4; L IS CC, HC = CH, N = N, O, S, SO2; R12 AND R12 'ARE H, ALKYL, ALKENYL, AMONG OTHERS; R13 IS H, ARYL, HETEROARYL, AMONG OTHERS. THE PREFERRED COMPOUNDS ARE ACID (2R, 3S) -2- (4'-METHOXY-BIPHENYL-4-SULFONYLAMINO-3- (4-METHYL-BENZYLOXY) -3-THIAZOL-2-IL-PROPIONICO, ACIDO (2R, 3S) -2- (4'-METHYLSULFANIL-BIPHENYL-4-SULFONYLAMINO) -3- (4-METHYL-BENZYLLOXY) -3-THIAZOL-2-IL-PROPIONICO, AMONG OTHERS. COMPOUND I IS INHIBITOR OF METALOPROTEASES AND MAY BE USEFUL TO TREAT ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15932099P | 1999-10-14 | 1999-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011003A1 true PE20011003A1 (en) | 2001-09-26 |
Family
ID=22572063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001097A PE20011003A1 (en) | 1999-10-14 | 2000-10-13 | METALOPROTEASE INHIBITORS |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1224171A1 (en) |
JP (1) | JP2003519100A (en) |
KR (1) | KR20020038951A (en) |
CN (1) | CN1379762A (en) |
AU (1) | AU8014500A (en) |
BR (1) | BR0014759A (en) |
CA (1) | CA2386485A1 (en) |
CO (1) | CO5271694A1 (en) |
CZ (1) | CZ20021161A3 (en) |
HU (1) | HUP0203118A3 (en) |
IL (1) | IL148893A0 (en) |
MA (1) | MA25561A1 (en) |
MX (1) | MXPA02003811A (en) |
NO (1) | NO20021748L (en) |
NZ (1) | NZ517983A (en) |
PE (1) | PE20011003A1 (en) |
PL (1) | PL355764A1 (en) |
SK (1) | SK5082002A3 (en) |
TR (1) | TR200200977T2 (en) |
WO (1) | WO2001027084A1 (en) |
ZA (1) | ZA200202207B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050227994A1 (en) * | 2002-03-27 | 2005-10-13 | Shionogi & Co., Ltd. | Decomposition inhibitor for extracellular matrix of cartilage |
AU2003304456A1 (en) | 2002-12-23 | 2005-03-16 | Wyeth Holdings Corporation | Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors |
WO2005061477A1 (en) | 2003-12-04 | 2005-07-07 | Wyeth | Biaryl sulfonamides as mmp inhibitors |
AU2003304638A1 (en) | 2003-12-04 | 2005-07-14 | Wyeth | Biaryl sulfonamides and methods for using same |
US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
EP1904465B1 (en) * | 2005-06-29 | 2010-03-31 | Janssen Pharmaceutica N.V. | Method of synthesis of imidazole-amino acid derivatives and related compounds |
CN107224675B (en) * | 2016-03-25 | 2023-06-02 | 南京中硼联康医疗科技有限公司 | Boron neutron capture therapy system |
EP3946301A4 (en) * | 2019-04-02 | 2023-08-09 | The University of Chicago | Remodilins for airway remodeling and organ fibrosis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69827940T2 (en) * | 1997-03-04 | 2005-06-09 | Pharmacia Corp.(N.D.Ges.D.Staates Delaware) | THIARYLSULFONAMID-hydroxamic acid |
WO1999006340A2 (en) * | 1997-07-31 | 1999-02-11 | The Procter & Gamble Company | Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
US6455522B1 (en) * | 1998-02-11 | 2002-09-24 | Bristol-Myers Squibb Pharma Company | Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
AU6542298A (en) * | 1998-03-04 | 1998-09-22 | Monsanto Company | Thioaryl sulfonamide hydroxamic acid compounds |
EP0967201A1 (en) * | 1998-05-20 | 1999-12-29 | Roche Diagnostics GmbH | Pharmaceutical agents containing sulfonamids as matrix metalloproteinase inhibitors |
SK12462001A3 (en) * | 1999-03-03 | 2002-04-04 | The Procter & Gamble Company | Dihetero-substituted metalloprotease inhibitors |
BR0008716A (en) * | 1999-03-03 | 2002-09-24 | Procter & Gamble | Metalloprotease inhibitors containing alkenyl or alkynyl |
-
2000
- 2000-10-12 SK SK508-2002A patent/SK5082002A3/en not_active Application Discontinuation
- 2000-10-12 IL IL14889300A patent/IL148893A0/en unknown
- 2000-10-12 CN CN00814334A patent/CN1379762A/en active Pending
- 2000-10-12 TR TR2002/00977T patent/TR200200977T2/en unknown
- 2000-10-12 EP EP00970820A patent/EP1224171A1/en not_active Withdrawn
- 2000-10-12 BR BR0014759-1A patent/BR0014759A/en not_active IP Right Cessation
- 2000-10-12 NZ NZ517983A patent/NZ517983A/en not_active Application Discontinuation
- 2000-10-12 MX MXPA02003811A patent/MXPA02003811A/en unknown
- 2000-10-12 HU HU0203118A patent/HUP0203118A3/en unknown
- 2000-10-12 CZ CZ20021161A patent/CZ20021161A3/en unknown
- 2000-10-12 AU AU80145/00A patent/AU8014500A/en not_active Abandoned
- 2000-10-12 KR KR1020027004754A patent/KR20020038951A/en not_active Application Discontinuation
- 2000-10-12 JP JP2001530105A patent/JP2003519100A/en not_active Withdrawn
- 2000-10-12 WO PCT/US2000/028194 patent/WO2001027084A1/en not_active Application Discontinuation
- 2000-10-12 CA CA002386485A patent/CA2386485A1/en not_active Abandoned
- 2000-10-12 PL PL00355764A patent/PL355764A1/en not_active Application Discontinuation
- 2000-10-13 PE PE2000001097A patent/PE20011003A1/en not_active Application Discontinuation
- 2000-10-13 CO CO00078367A patent/CO5271694A1/en not_active Application Discontinuation
-
2002
- 2002-01-01 ZA ZA200202207A patent/ZA200202207B/en unknown
- 2002-04-12 NO NO20021748A patent/NO20021748L/en not_active Application Discontinuation
- 2002-04-12 MA MA26597A patent/MA25561A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0203118A2 (en) | 2003-01-28 |
MA25561A1 (en) | 2002-10-01 |
HUP0203118A3 (en) | 2003-05-28 |
KR20020038951A (en) | 2002-05-24 |
BR0014759A (en) | 2002-07-02 |
EP1224171A1 (en) | 2002-07-24 |
NO20021748L (en) | 2002-06-14 |
IL148893A0 (en) | 2002-09-12 |
CZ20021161A3 (en) | 2002-08-14 |
WO2001027084A1 (en) | 2001-04-19 |
CA2386485A1 (en) | 2001-04-19 |
ZA200202207B (en) | 2002-12-24 |
JP2003519100A (en) | 2003-06-17 |
PL355764A1 (en) | 2004-05-17 |
CO5271694A1 (en) | 2003-04-30 |
SK5082002A3 (en) | 2002-10-08 |
TR200200977T2 (en) | 2002-08-21 |
AU8014500A (en) | 2001-04-23 |
MXPA02003811A (en) | 2002-09-30 |
NO20021748D0 (en) | 2002-04-12 |
NZ517983A (en) | 2004-01-30 |
CN1379762A (en) | 2002-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0013041A (en) | Heterocyclic compound and pharmaceutical composition to treat and prevent diseases mediated by cgmp-pde, its use and method | |
ES2167676T3 (en) | EPOXI IGNIFUGAS RESINS AND IGNIFUGENT AGENTS FOR EPOXI RESINS. | |
DK0747374T3 (en) | Sulfonamide-substituted benzopyrans as potassium channel activators | |
DK633088A (en) | collagenase | |
GR68522B (en) | ||
PE20011003A1 (en) | METALOPROTEASE INHIBITORS | |
PT90912A (en) | PROCESS FOR THE PREPARATION OF THYOPHENOL DERIVATIVES | |
PE20011137A1 (en) | METALOPROTEASE INHIBITORS CONTAINING N-SUBSTITUTED HETEROCYCLIC SIDE CHAINS | |
DK709088A (en) | thiol derivatives | |
RO89144A (en) | ERBICIDA LICHIDA COMPOSITION | |
WO1999023092A3 (en) | 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them | |
GR81941B (en) | ||
DE60000500D1 (en) | SUBSTITUTED N- (PIPERIDIN-4-YL) -4H-3,1-BENZO (THIA / OXA) ZIN-2-AMINE, THEIR PRODUCTION AND THERAPEUTIC USE | |
DE60011226D1 (en) | SUBSTITUTED 1- (PIPERIDIN-4-YL) -3- (ARYL) -ISOTHIO UREAS, THEIR PRODUCTION AND THERAPEUTIC USE | |
ES2190610T3 (en) | SYNTHESIS OF 3-CARBOMETOXI-4,5-DIMETHYLETHOPHEN. | |
ATE74604T1 (en) | SUBSTITUTED PYRIMIDOCHINOXALINES. | |
GB1039874A (en) | New isoquinoline derivatives | |
ES8201994A1 (en) | Procedure for the obtaining of new piridinic derivatives of pharmacological interest (Machine-translation by Google Translate, not legally binding) | |
KR830001877A (en) | Method for preparing benzamidine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |